Post Holdings to Acquire Weetabix for £1.4 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Post Holdings (POST) PT Raised to $105 at Pivotal Research Following Announced Weetabix Acquisition
April 18, 2017 10:45 AM EDTPivotal Research raised its price target on Post Holdings (NYSE: POST) to $105.00 (from $95.00) while maintaining a Buy rating following the company's announced acquisition of Weetabix Ltd. for $1.778 billion. POST also pre-announced 2Q earnings results at $228 million EBITDA on $1.25 billion of sales, both in-line... More
